The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the opportunity to participate in the European Commission’s structured dialogue on supply chain security.
The EFPIA claims that it is critical that any proposals from the structured dialogue take into account the nuances between the different actors across the medicines and vaccines supply chains.
"Europe needs longer-term investment, incentives and global regulatory harmonization in order to build a strong innovative manufacturing and supply ecosystem"EUROSTAT data shows that the European Union (EU) is a strong exporter of pharmaceutical products, and in terms of imports, is resilient because most come from the EU itself, the group stressed.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze